Northwest Biotherapeutics, Inc. (NWBO) has a market capitalization of $308.14M and trades at $0.20. The 52-week range is 0.18-0.48.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -2.9, Earnings Per Share (EPS) of $-0.07, annual revenue of $1.38M.
The stock has a beta of -0.77, operates in the Healthcare sector.
